Measures Against Large-Scale Purchases of Shares
First written in FY2016. 20 of 27 entries say "Restated". Latest entry: FY2026.
15 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「If the proposal is approved as originally submitted, the effective period will run from the close of the 103rd Annual General Meeting of Shareholders held on 26 June 2026 until the close of the annual shareholders’ meeting scheduled for June 2029.」
For the existing measures against large-scale purchases, the Company submitted a proposal to partially amend and continue the measures at the June 2026 shareholders’ meeting, updating the framework to extend the effective period through June 2029 subject to approval. - FY2026-H1RestatedAnnual report
「At the 100th ordinary general meeting of shareholders held on 29 June 2023, the company passed a resolution to continue its response measures for large-scale purchases of the company's shares and other equity securities (the "Response Measures") and obtained shareholder approval.」
The Company continued to disclose the measures against large-scale purchases approved for continuation at the shareholders’ meeting held on 29 June 2023. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2026. - FY2024-Q3RestatedAnnual report
「At the 100th ordinary general meeting of shareholders held on 29 June 2023, the company passed a resolution to continue its response measures for large-scale purchases of the company's shares and other equity securities (the "Response Measures") and obtained shareholder approval.」
The Company continued to disclose the measures against large-scale purchases approved for continuation at the annual shareholders’ meeting held on 29 June 2023. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2026, and the mechanisms covering purchases of 20% or more, the Board of Directors’ evaluation period, and recommendations by the Independent Committee were also maintained. - FY2024-Q1RestatedAnnual report
「At the 100th ordinary general meeting of shareholders held on 29 June 2023, the company passed a resolution to continue its response measures for large-scale purchases of the company's shares and other equity securities (the "Response Measures") and obtained shareholder approval.」
The Company continued to disclose the measures against large-scale purchases approved for continuation at the annual shareholders’ meeting held on 29 June 2023. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2026. - FY2023AdvancedAnnual report
「At the 100th ordinary general meeting of shareholders held on 29 June 2023, the company passed a resolution to continue its response measures for large-scale purchases of the company's shares and other equity securities (the "Response Measures") and obtained shareholder approval.」
The measures against large-scale purchases were approved for continuation at the shareholders’ meeting, and their effective period was extended until the close of the annual shareholders’ meeting scheduled for June 2026. - FY2022-Q3RestatedAnnual report
「At the Company’s 97th Annual General Meeting of Shareholders held on 25 June 2020, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
For the measures against large-scale purchases, the Company continued to disclose approval for their continuation at the shareholders’ meeting held on 25 June 2020, procedures covering purchases of 20% or more, the Board of Directors’ evaluation period, and an effective period extending until the shareholders’ meeting scheduled for June 2023. - FY2022-Q2RestatedAnnual report
「At the Company’s 97th Annual General Meeting of Shareholders held on 25 June 2020, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
For the measures against large-scale purchases, the Company continued to disclose approval for their continuation at the shareholders’ meeting held on 25 June 2020, procedures covering purchases of 20% or more, a 60-day or 90-day Board of Directors’ evaluation period, and an effective period extending until the shareholders’ meeting scheduled for June 2023. - FY2022-Q1RestatedAnnual report
「At the Company’s 97th Annual General Meeting of Shareholders held on 25 June 2020, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
The Company continued the measures against large-scale purchases. It disclosed procedures covering purchases of 20% or more, a 60-day or 90-day Board of Directors’ evaluation period, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2023. - FY2021-Q1RestatedAnnual report
「At the Company’s 97th Annual General Meeting of Shareholders held on 25 June 2020, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
The Company again disclosed that the measures against large-scale purchases had been approved for continuation at the annual shareholders’ meeting held on 25 June 2020. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2023. - FY2020AdvancedAnnual report
「At the Company’s 97th Annual General Meeting of Shareholders held on 25 June 2020, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
The measures against large-scale purchases were approved for continuation at the shareholders’ meeting. Their effective period was set to end at the close of the 100th Annual General Meeting of Shareholders scheduled for June 2023. - FY2020-Q2RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
The Company continued to disclose measures covering large-scale purchases of 20% or more, including information provision, a 60-day or 90-day Board of Directors’ evaluation period, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2020. - FY2020-Q1RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval. The Measures will remain effective until the close of the annual shareholders’ meeting relating to the last fiscal year ending within 3 years from the close of the 94th Annual General Meeting of Shareholders held on 29 June 2017.」
The Company continued the measures covering purchases of 20% or more, the Board of Directors’ evaluation period, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2020. - FY2019RestatedAnnual report
「The Measures will remain effective until the close of the annual shareholders’ meeting relating to the last fiscal year ending within 3 years from the close of the 94th Annual General Meeting of Shareholders held on 29 June 2017.」
The Company continued the measures covering purchases of 20% or more, the Board of Directors’ evaluation period, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights. - FY2019-Q3RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
The Company continued to disclose measures covering large-scale purchases of 20% or more, including information provision, a 60-day or 90-day Board of Directors’ evaluation period, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2020. - FY2019-Q2RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”), and obtained shareholders’ approval.」
The Company continued to disclose measures covering large-scale purchases of 20% or more, including information provision, a 60-day or 90-day Board of Directors’ evaluation period, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights. The effective period was set to end at the close of the annual shareholders’ meeting scheduled for June 2020. - FY2018RestatedAnnual report
「The Measures will remain effective until the close of the annual shareholders’ meeting relating to the last fiscal year ending within 3 years from the close of the 94th Annual General Meeting of Shareholders held on 29 June 2017.」
The Company continued to disclose measures covering large-scale purchases of 20% or more, with an effective period lasting until the close of the shareholders’ meeting scheduled for June 2020. - FY2018-Q3RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”).」
For the measures against large-scale purchases, the Company continued to disclose procedures covering purchases of 20% or more, the Board of Directors’ evaluation period, recommendations by the Independent Committee, the gratis allotment of stock acquisition rights, and the effective period. - FY2018-Q2RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”). The Measures will remain effective until the close of the annual shareholders’ meeting relating to the last fiscal year ending within 3 years from the close of the 94th Annual General Meeting of Shareholders held on 29 June 2017.」
For the measures against large-scale purchases, the Company continued to disclose shareholder approval for their continuation, procedures covering purchases of 20% or more, the Board of Directors’ evaluation period, recommendations by the Independent Committee, the gratis allotment of stock acquisition rights, and the effective period extending until the annual shareholders’ meeting relating to a fiscal year ending within 3 years. - FY2018-Q1RestatedAnnual report
「At the Company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to continue the measures concerning large-scale purchases of the Company’s shares and other securities (the “Measures”). The Measures will remain effective until the close of the annual shareholders’ meeting relating to the last fiscal year ending within 3 years from the close of the 94th Annual General Meeting of Shareholders held on 29 June 2017.」
The continuation of the measures against large-scale purchases and their effective period, lasting until the annual shareholders’ meeting relating to a fiscal year ending within 3 years, continued to be disclosed. - FY2017AdvancedAnnual report
「At the company’s 94th Annual General Meeting of Shareholders held on 29 June 2017, the company passed a resolution to continue its response policy concerning large-scale purchases of the company’s shares and other securities (the “Response Policy”).」
The measures against large-scale purchases were approved for continuation at the shareholders’ meeting, with their effective period set to end at the close of the annual shareholders’ meeting relating to the last fiscal year ending within 3 years. - FY2017-Q3RestatedAnnual report
「At the company’s 91st Annual General Meeting of Shareholders held on 27 June 2014, the company passed a resolution to continue its response policy concerning large-scale purchases of the company’s shares and other securities (the “Response Policy”).」
The company continues to describe its response policy for large-scale purchases, including purchases of 20% or more, information disclosure, a 60- or 90-day evaluation period for the board of directors, recommendations by the Independent Committee, and the gratis allotment of stock acquisition rights and other mechanisms. The policy remains effective until the conclusion of the Annual General Meeting of Shareholders scheduled for June 2017. - FY2017-Q2RestatedAnnual report
「At the company’s 91st Annual General Meeting of Shareholders held on 27 June 2014, the company passed a resolution to continue its response policy concerning large-scale purchases of the company’s shares and other securities (the “Response Policy”).」
The company continues to describe its response policy for large-scale purchases without change. There have been no material changes to the mechanisms covering purchases of 20% or more, letters of intent and information disclosure, a 60- or 90-day evaluation period for the board of directors, recommendations by the Independent Committee, the gratis allotment of stock acquisition rights and other matters, or to the effective period through the conclusion of the Annual General Meeting of Shareholders scheduled for June 2017. - FY2017-Q1RestatedAnnual report
「At the company’s 91st Annual General Meeting of Shareholders held on 27 June 2014, the company passed a resolution to continue its response policy concerning large-scale purchases of the company’s shares and other securities (the “Response Policy”).」
The company continues to describe its response policy for large-scale purchases. The policy covers purchases of 20% or more and provides for a 60- or 90-day evaluation period for the board of directors, recommendations by the Independent Committee, the gratis allotment of stock acquisition rights and other mechanisms. Its effective period runs until the conclusion of the Annual General Meeting of Shareholders scheduled for June 2017. - FY2016First statedAnnual report
「At the company’s 91st Annual General Meeting of Shareholders held on 27 June 2014, the company passed a resolution to continue its response policy concerning large-scale purchases of the company’s shares and other securities (the “Response Policy”).」
The policy covers large-scale purchases of 20% or more and provides for information disclosure, a 60- or 90-day evaluation period for the board of directors, recommendations by the Independent Committee and the gratis allotment of stock acquisition rights. It remains effective until the conclusion of the Annual General Meeting of Shareholders scheduled for June 2017.